Predict your next investment

Adastra Pharmaceuticals company logo
HEALTHCARE | Drug Development
adastrarx.com

See what CB Insights has to offer

Total Raised

$90.65M

Investors Count

10

Deal Terms

4

Adastra Pharmaceuticals Funding, Adastra Pharmaceuticals Valuation & Adastra Pharmaceuticals Revenue

13 Fundings

Adastra Pharmaceuticals's latest funding round was a Series E - II for $1.4M on November 1, 2019.

Adastra Pharmaceuticals's valuation in September 2015 was $81.26M.

Date

Round

Amount

Investors

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Revenue

Sources

11/1/2019

Series E - II

$1.4M

1

4/24/2019

Series E

$2.25M

1

2/12/2019

Convertible Note - III

$1M

1

11/15/2016

Series D

$99M

10

9/2/2015

Series C

$99M

$81.26M

10

Date

11/1/2019

4/24/2019

2/12/2019

11/15/2016

9/2/2015

Round

Series E - II

Series E

Convertible Note - III

Series D

Series C

Amount

$1.4M

$2.25M

$1M

$99M

$99M

Investors

Valuation

$81.26M

Revenue

Sources

1

1

1

10

10

Adastra Pharmaceuticals Deal Terms

4 Deal Terms

Adastra Pharmaceuticals's deal structure is available for 4 funding rounds, including their Series C from September 02, 2015.

Round

Series C

Series B

Series A - II

Series A

Funding Date

$99M

$99M

$99M

$99M

Pre-Money Valuation

$99M

$99M

Post-Money Valuation

$99M

$99M

Amount Raised

$99M

$99M

$99M

$99M

Shares Authorized

Issuance Price

$99M

$99M

$99M

Dividend Rate

$99M

$99M

$99M

Liquidation Preferences

$99M

$99M

$99M

Liquidation Price

Participation

$99M

$99M

$99M

Conversion Price

Anti Dilution

$99M

$99M

$99M

General Voting

$99M

$99M

$99M

$99M

Board Voting

$99M

$99M

$99M

$99M

Par Value

Round

Funding Date

Pre-Money Valuation

Post-Money Valuation

Amount Raised

Shares Authorized

Issuance Price

Dividend Rate

Liquidation Preferences

Liquidation Price

Participation

Conversion Price

Anti Dilution

General Voting

Board Voting

Par Value

Series C

$99M

$99M

$99M

$99M

Series B

$99M

$99M

$99M

$99M

$99M

$99M

$99M

$99M

$99M

Series A - II

$99M

$99M

$99M

$99M

$99M

$99M

$99M

$99M

$99M

$99M

$99M

Series A

$99M

$99M

$99M

$99M

$99M

$99M

$99M

$99M

$99M

$99M

$99M

Adastra Pharmaceuticals Investors

10 Investors

Adastra Pharmaceuticals has 10 investors. Domain Associates invested in Adastra Pharmaceuticals's Series E - II funding round.

First funding

Last Funding

Investor

Rounds

Board Seats

Type

Location

3/21/2007

11/1/2019

10
Series A, Series A - II (2010), Convertible Note - II (2012), Series C (2015), Series D (2016), Series E (2019), Convertible Note (2011), Series B (2013), Convertible Note - III (2019), Series E - II (2019)

Venture Capital

New Jersey

3/21/2007

4/24/2019

6
Series A, Series A - II (2010), Convertible Note - II (2012), Series E (2019), Convertible Note (2011), Series B (2013)

Venture Capital

New Jersey

4/28/2011

9/3/2013

2
Convertible Note, Series B (2013)

Corporation

Japan

00/00/0000

00/00/0000

Rusnano

Subscribe to see more

Government

Russian Federation

00/00/0000

00/00/0000

Morgenthaler Ventures

Subscribe to see more

Venture Capital

California

First funding

3/21/2007

3/21/2007

4/28/2011

00/00/0000

00/00/0000

Last Funding

11/1/2019

4/24/2019

9/3/2013

00/00/0000

00/00/0000

Investor

Rusnano

Morgenthaler Ventures

Rounds

10
Series A, Series A - II (2010), Convertible Note - II (2012), Series C (2015), Series D (2016), Series E (2019), Convertible Note (2011), Series B (2013), Convertible Note - III (2019), Series E - II (2019)
6
Series A, Series A - II (2010), Convertible Note - II (2012), Series E (2019), Convertible Note (2011), Series B (2013)
2
Convertible Note, Series B (2013)

Subscribe to see more

Subscribe to see more

Board Seats

Type

Venture Capital

Venture Capital

Corporation

Government

Venture Capital

Location

New Jersey

New Jersey

Japan

Russian Federation

California

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.